Abstract
Forty-seven patients were submitted to 68 radioimmunoscintigraphic investigations for primary or recurrent colorectal cancer. Immunoscintigraphy with Immu-4 tm correctly detected 28 primary colorectal cancers of 29 and 12 of 12 recurrent colorectal cancers. Overall accuracy was 93.75 percent in primary and 91.6 percent in recurrent colorectal cancer. Immunoscintigraphy had a decisive influence on treatment planning in every third primary colorectal cancer patient and was by far superior to CT scan in the detection of early recurrences, especially in patients with a history of abdominoperineal or low anterior resection. Immu-4 tm scintigraphy is a safe and convenient diagnostic approach to colorectal cancer. Because radioactivity is acceptably low and the method is absolutely free of side effects, there are no objections to the repeated use of immunoscintigraphy which provides important information in primary diagnosis as well as in the follow-up of colorectal cancer patients.
Similar content being viewed by others
References
Moss AA. Imaging of colorectal carcinoma. Radiology 1989;170:308–10.
Freeny PC, Marks WM, Ryan JA, Bolen JW. Colorectal carcinoma evaluation with CT: preoperative staging and detection of recurrences. Radiology 1986;158: 347–53.
Pickren NJ, Tsukaday P, Lane WW. Liver metastases—analysis and autopsy data. In: Weiss L, Gilver HA, eds. Liver metastases. Boston: GK Hall, 1982: 2–18.
Finlay IG, McArdle CS. Occult hepatic metastases in colorectal cancer. Br J Surg 1986;73:732–5.
Lind P, Lechner P, Arian-Schad K,et al. Anti-carcinoembryonic antigen immunoscintigraphy (Tc-99m MAb BW 431/26) and serum-CEA-levels in patients with suspected primary and recurrent colorectal carcinoma. J Nucl Med 1991;32:1319–25.
Kronberger L, Lechner P, Lind P, Fueger F, Germann R, Cesnik H. Results of CEA-assays in diagnosis and follow-up of colorectal cancer. In: Kronberger L, ed. Abstract book of the XIIIth Biennial Congress of the International Society of University Colon and Rectal Surgeons, June 24–28 Graz, Austria. Wien: Blackwell MZV, 1990:90.
Bosslet K, Lueben G, Schwarz A,et al. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes on carcinoembryonic antigen. Int J Cancer 1985;36: 75–84.
Koehler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specifity. Nature 1975;256:494–7.
Goldenberg DM, Ford EH, Lee RE,et al. Cancer imaging with a new 99m-Tc-antibody method (abstr). Eur J Nucl Med 1989;15:426.
Lind P, Lechner P, Hausmann B,et al. Development of human antimouse antibodies (HAMA) after single and repeated diagnostic application of intact murine monoclonal antibodies. Antibody Immunoconjugates Radiopharmaceut 1991;4:811–18.
Serafini AN, Garty I, Jacobi AM. Monoclonal antibody imaging, clinical and technical perspectives. Antibody Immunoconjugates Radiopharmaceut 1989;2: 225–34.
Chang LT. A method of attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638–43.
Bischof-Delaloye A, Delaloye B, Buchegger F, Mach JP. Immunoscintigraphy with123I-labeled monoclonal anti-carcinoembryonic antibodies in the diagnosis and follow-up of patients with colorectal carcinoma. In: Eber O, Lind P, Langsteger W, eds. Modern aspects of tumor diagnosis and treatment. Wien: Blackwell MZV, 1991:56–63.
Haller DG. Monoclonal antibody imaging in the management of patients with colorectal cancer. J Clin Oncol 1988;6:1213–5.
Doerr R, Abdel-Nabi H, Krag D, Mitchell E. Radiolabeled antibody imaging in the management of colorectal cancer—results of a multicenter clinical study. Ann Surg 1991;214:118–24.
Lind P, Langsteger W, Koeltringer P,et al.99mTc-labeled monoclonal anti-carcino-embryonic antibody (BW 431/26). Clinical results in the detection of colorectal carcinomas and recurrences. Scand J Gastroenterol 1989;24:1205–11.
Klose KJ, Dueber C, Kempf P. Stellenwert der computertomographie in der diagnostik des lokalen beckenrezidivs. Fortschr Röntg Neun 1982;136: 538–42.
Author information
Authors and Affiliations
Additional information
Read at the meeting of The American Society of Colon and Rectal Surgeons, San Francisco, California, June 7 to 12, 1992.
About this article
Cite this article
Lechner, P., Lind, P., Binter, G. et al. Anticarcinoembryonic antigen immunoscintigraphy with a99mTc-Fab′ fragment (Immu 4TM) in primary and recurrent colorectal cancer. Dis Colon Rectum 36, 930–935 (1993). https://doi.org/10.1007/BF02050628
Issue Date:
DOI: https://doi.org/10.1007/BF02050628